0%
0 / 15 answered
Biological Bases of Psychological Disorders (7A) Practice Test
•15 QuestionsQuestion
1 / 15
Q1
In a double-blind, placebo-controlled study of major depressive disorder (MDD), researchers measured cerebrospinal fluid (CSF) 5-hydroxyindoleacetic acid (5-HIAA; a serotonin metabolite) at baseline and after 6 weeks of treatment. Participants were randomized to an SSRI or placebo. Depressive symptoms were assessed with the Hamilton Depression Rating Scale (HDRS; higher = worse).
Data (mean ± SD):
- SSRI group (n = 28): baseline CSF 5-HIAA $= 19.8 \pm 4.1$ ng/mL; week-6 CSF 5-HIAA $= 27.6 \pm 5.0$ ng/mL; HDRS change $= -11.2 \pm 6.0$
- Placebo group (n = 27): baseline CSF 5-HIAA $= 20.3 \pm 4.3$ ng/mL; week-6 CSF 5-HIAA $= 21.1 \pm 4.6$ ng/mL; HDRS change $= -3.1 \pm 5.4$
Within the SSRI group, increase in 5-HIAA correlated with symptom improvement ($r = -0.52$).
Based on these findings, which conclusion regarding serotonergic signaling is most consistent with the data?
In a double-blind, placebo-controlled study of major depressive disorder (MDD), researchers measured cerebrospinal fluid (CSF) 5-hydroxyindoleacetic acid (5-HIAA; a serotonin metabolite) at baseline and after 6 weeks of treatment. Participants were randomized to an SSRI or placebo. Depressive symptoms were assessed with the Hamilton Depression Rating Scale (HDRS; higher = worse).
Data (mean ± SD):
- SSRI group (n = 28): baseline CSF 5-HIAA $= 19.8 \pm 4.1$ ng/mL; week-6 CSF 5-HIAA $= 27.6 \pm 5.0$ ng/mL; HDRS change $= -11.2 \pm 6.0$
- Placebo group (n = 27): baseline CSF 5-HIAA $= 20.3 \pm 4.3$ ng/mL; week-6 CSF 5-HIAA $= 21.1 \pm 4.6$ ng/mL; HDRS change $= -3.1 \pm 5.4$ Within the SSRI group, increase in 5-HIAA correlated with symptom improvement ($r = -0.52$).
Based on these findings, which conclusion regarding serotonergic signaling is most consistent with the data?